Supplementary protection
LT - Anti-il-12 antikūnai, kompozicijos, būdai ir panaudojimai
EN - ANTI-IL-12 ANTIBODIES, COMPOSITIONS, METHODS AND USES
SPC
| (11) |
Number of the document |
C 1309692 |
| (68) |
Number of the document |
1309692
|
| (21) |
Application number for Supplementary Protection Certificate |
PA 2009 002 |
| (22) |
Date of filing the application |
2009-05-15 |
| (41) |
Date of publication of the application |
2009-07-27 |
|
Date of publication of SPC |
2009-12-28 |
| (24) |
Date of coming into effect of SPC |
2021-08-08 |
Applicant
| (71) |
Centocor Ortho Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
Grantee
| (73) |
Janssen Biotech, Inc.,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
Attorney or representative
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
| (93) |
EU/1/08/494/001-002, C(2009)236, 2009-01-16
|
Calculated date of expiry of the SPC
| (94) |
2024-01-20 |
Name of the product protected by the basic patent
| (95) |
Ustekinumabum |
Paediatric extension
|
Request filed |
SPC extension granted until |
Request refused |
|
2020-02-21 |
2024-07-20 |
|
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2023-07-17 |
|
347.00
EUR
|
